Internal Medicine, Hematology & Oncology · La Jolla, CA
NPI
1053471318
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
10710 N Torrey Pines Rd
La Jolla, CA, 92037
Phone (858) 554-8788
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
543 services
Medicare patients, 2024
113
Average age 68
Drug cost, 2024
$2.5M
743 prescriptions
Company payments, 2025
$527
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Divya T Koura was code 99233 (hospital e&m - subsequent), 232 times for 43 patients. In total Divya T Koura billed 543 services in 14 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 232 | 43 | $93.35 | $22K |
| 99215 Office E&M - Established | Facility | 113 | 44 | $109.31 | $12K |
| 99214 Office E&M - Established | Facility | 29 | 18 | $73.70 | $2,137 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 29 | 15 | $13.49 | $391 |
| 99214 Office E&M - Established | Office | 27 | 12 | $109.10 | $2,946 |
| 99442 Telephone Services | Facility | 21 | 16 | $45.84 | $963 |
| 99213 Office E&M - Established | Office | 15 | 12 | $71.37 | $1,071 |
| 99239 Hospital Discharge Management | Facility | 14 | 14 | $94.11 | $1,318 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $140.67 | $1,547 |
By year: 2022 $50K for 559 services; 2023 $65K for 676 services; 2024 $49K for 543 services.
Medicare prescription drug claims, 2024
In 2024, the drug Divya T Koura prescribed most often to Medicare patients was Acyclovir, with 124 prescriptions and refills. In total Divya T Koura wrote 743 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 124 | 162 | 29 | $1,589 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 40 | 63 | 15 | $161 |
| Jakafi Ruxolitinib Phosphate | 38 | 38 | Under 11 | $562K |
| Gabapentin Generic | 33 | 52 | Under 11 | $575 |
| Iclusig Ponatinib Hcl | 31 | 31 | Under 11 | $594K |
| Prednisone Generic | 30 | 35 | Under 11 | $286 |
| Eliquis Apixaban | 28 | 28 | Under 11 | $17K |
| Famotidine Generic | 22 | 26 | Under 11 | $73.75 |
| Ondansetron Odt Ondansetron | 22 | 22 | Under 11 | $296 |
| Atovaquone Generic | 20 | 20 | Under 11 | $9,369 |
| Brukinsa Zanubrutinib | 20 | 20 | Under 11 | $176K |
| Azithromycin Generic | 20 | 26 | Under 11 | $126 |
| Revlimid Lenalidomide | 16 | 16 | Under 11 | $312K |
| Cyclosporine Modified Cyclosporine, Modified | 14 | 14 | Under 11 | $919 |
| Oxycodone Hcl Generic | 13 | 13 | Under 11 | $70.58 |
Brand drugs: 206 claims; generic drugs: 537 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Divya T Koura $527 ($527 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $137.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $137 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $105 |
| GlaxoSmithKline, LLC. GSK | 2 | $46.85 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $30.72 |
| Incyte Corporation INCY | 1 | $27.99 |
| BeOne Medicines USA, Inc. ONC | 1 | $26.95 |
| Kite Pharma, Inc. GILD | 1 | $26.37 |
| Adc Therapeutics America, Inc. | 1 | $25.18 |
| Pfizer Inc. PFE | 1 | $23.32 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $22.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.